Comprehensive geriatric assessment in patients undergoing transcatheter aortic valve implantation – results from the CGA-TAVI multicentre registry

Table 9 Periprocedural outcomes

	Mean ± SD / n/N (%)
Device success (VARC-2)^a
Absence of procedural mortality	70/70 (100.0)
Correct positioning of THV	70/70 (100.0)
Intended performance of THV	70/70 (100.0)
Intraoperative complications^b	12/70 (17.1)
Vascular complications requiring treatment^c	7/70 (10.0)
Access-related complications (dissection, rupture)	4/71 (5.6)
Conversion to open surgery (%)	0/70 (0.0)
Paravalvular regurgitation (%)
None/trace	46/70 (65.7)
Mild	22/70 (31.4)
Moderate	2/70 (2.9)
Severe	0/70 (0.0)
Transvalvular leakage (%)
None/trace	62/70 (88.6)
Mild	8/70 (11.4)
Moderate/severe	0/70 (0.0)
AV peak gradient (mmHg)	20.0 ± 12.4 (n = 31)
AV mean gradient (mmHg)	11.3 ± 7.2 (n = 32)

Legend: THV transcatheter heart valve, AV aortic valve
^aValve Academic Research Consortium criteria: absence of procedural mortality, correct positioning of a single prosthetic heart valve into proper anatomical position, and intended performance of the prosthetic heart valve (no prosthesis–patient mismatch) and mean aortic valve gradient
^bIncludes access-related complications (8 pts), asystole/arrhythmia (2 pts), haemorrhagic stroke (1 pt) [one patient no further information available]
^cIncludes aneurysm, haematoma, pericardial haematoma/effusion (2 pts), apical bleeding (1 pt)

ISSN: 1471-2261